Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions is a research paper published in Medicinal Research Reviews (2020). On theSindex it has a DataRank of 0. It has been cited 415 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIGMS NIH HHS
Grant: R35 GM133504
NIAID NIH HHS
Grant: R01 AI124465
NIA NIH HHS
Grant: R01 AG057907
NIA NIH HHS
Grant: U01 AG058635
NIA NIH HHS
Grant: R01 AG072562
NIA NIH HHS
Grant: RF1 AG054014
NIA NIH HHS
Grant: R01 AG068030
NIA NIH HHS
Grant: RF1 AG057440
NIA NIH HHS
Grant: R01 AG062355
NIA NIH HHS
Grant: U01 AG052411
NIA NIH HHS
Grant: RF1 AG059319
NIA NIH HHS
Grant: U01 AG046170
National Institutes of Health
Grant: 5U01AG052411-03
Identification and characterization of AD risk networks using multi-dimensional "omics" data
National Institutes of Health
Grant: 1RF1AG054014-01
Molecular Characterization and Validation of Gender Differences in Alzheimers Disease Pathogenesis
National Institutes of Health
Grant: 5U01AG058635-03
Genomic approach to identification of microglial networks involved in Alzheimer disease risk
National Institutes of Health
Grant: 5R01AG062355-02
Systems modeling of shared and distinct molecular mechanisms underlying comorbid Major Depressive Disorder and Alzheimer's disease
National Institutes of Health
Grant: 5R01AG057907-03
Integrative Network Modeling of Cognitive Resilience to Alzheimer's Disease
National Institutes of Health
Grant: 3U01AG046170-01S1
Accelerating Medicine Partnership in Alzheimer's Disease: Enabling collaborative
National Institutes of Health
Grant: 1RF1AG057440-01
Towards a comprehensive signaling pathway map of parahippocampal vulnerability in Alzheimers Disease
National Institutes of Health
Grant: 1R35GM133504-01
Structural Studies and Drug Discovery Illuminate Serotonin Pharmacology
National Institutes of Health
Grant: 5R01AG068030-05
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease
FWCI
14.44
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of ProfhEX: AI-based platform for small molecules liability profiling
Additional file 1 of ProfhEX: AI-based platform for small molecules liability profiling
Additional file 1 of Preclinical translational platform of neuroinflammatory disease biology relevant to neurodegenerative disease
Additional file 1 of Preclinical translational platform of neuroinflammatory disease biology relevant to neurodegenerative disease
Additional file 2 of Preclinical translational platform of neuroinflammatory disease biology relevant to neurodegenerative disease
Additional file 2 of Preclinical translational platform of neuroinflammatory disease biology relevant to neurodegenerative disease
Additional file 3 of Preclinical translational platform of neuroinflammatory disease biology relevant to neurodegenerative disease
Additional file 3 of Preclinical translational platform of neuroinflammatory disease biology relevant to neurodegenerative disease
Additional file 4 of Preclinical translational platform of neuroinflammatory disease biology relevant to neurodegenerative disease
Additional file 4 of Preclinical translational platform of neuroinflammatory disease biology relevant to neurodegenerative disease